전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
trombocytenaggregatieremmers
antimycobacterials
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
antithrombotica [trombocytenaggregatieremmers]
[x]antithrombotic drug causing advers effect in therap use
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
nsaid's/trombocytenaggregatieremmers
nsaids/platelet aggregation inhibitors
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
of andere trombocytenaggregatieremmers, zoals
or other inhibitors of platelet aggregation, such as
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
trombocytenaggregatieremmers met uitzondering van heparine, atc-code:
platelet aggregation inhibitors excluding heparin, atc code:
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
trombocytenaggregatieremmers moeten worden gestopt volgens de aanwijzingen in de voorschrijfinformatie van de fabrikant.
platelet aggregation inhibitors should be discontinued as suggested by the manufacturer’s prescribing information.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
de informatie dat patiënten ten tijde van de injectie geen trombocytenaggregatieremmers of andere anticoagulantia mogen gebruiken
that patients should not be taking anti-platelet or other anti-coagulation medicinal products at the time of injection
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
farmacotherapeutische categorie: antitrombotische middelen, trombocytenaggregatieremmers exclusief heparine, atc-code: b01ac26.
pharmacotherapeutic group: antithrombotic agents, platelet aggregation inhibitors excluding heparin, atc code: b01ac26.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
farmacotherapeutische categorie: antitrombotische geneesmiddelen, trombocytenaggregatieremmers met uitzondering van heparine, atc-code: b01ac11
pharmacotherapeutic group: antithrombotic agents, platelet aggregation inhibitors excluding heparin, atc code: b01ac11
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
de bloedingsvoorvallen werden op dezelfde wijze behandeld als voor andere trombocytenaggregatieremmers en omvatte het aanpakken van de bron van de bloeding en het geven van ondersteunende zorg.
bleeding events were treated in the same manner as for other antiplatelet agents including addressing the source of bleeding while providing supportive care.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
als een patiënt electieve chirurgie ondergaat en het antitrombocyteneffect ongewenst is, moet worden gestopt met trombocytenaggregatieremmers volgens de aanwijzingen in de voorschrijfinformatie van de fabrikant.
if a patient is to undergo elective surgery and anti-platelet effect is not desired, platelet aggregation inhibitors should be discontinued as directed by the manufacturer’s prescribing information.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
zontivity bevat een werkzame stof met de naam vorapaxar en het behoort tot een groep geneesmiddelen die trombocytenaggregatieremmers (plaatjesremmers) worden genoemd.
zontivity contains an active substance called vorapaxar, and it belongs to a group of medicines called ‘anti-platelet medicines.’
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
aanvullende medische handelingen kunnen omvatten: het staken van anticoagulantia en/of trombocytenaggregatieremmers, het tegengaan van anticoagulatie of het ondersteunen met trombocyten.
additional medical management may include cessation of anticoagulant and/or antiplatelet therapy, reversal of anticoagulation, or platelet support.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
gedurende minimaal één week voorafgaand aan de beeninjecties of één dag na de injecties mogen geen trombocytenaggregatieremmers of andere anticoagulantia worden ingenomen (zie rubriek 4.3).
anti-platelet or other anti-coagulant medicinal products must not be taken for at least one week before the leg injections or one day after the injection (see section 4.3).
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
eptifibatide, een synthetisch cyclisch heptapeptide dat zes aminozuren bevat, inclusief één cysteïnamide en één mercaptopropionyl (desaminocysteïnyl) residu, is een trombocytenaggregatieremmer en behoort tot de klasse van de rgd (arginine-glycine-aspartaat) mimetica.
eptifibatide, a synthetic cyclic heptapeptide containing six amino acids, including one cysteine amide and one mercaptopropionyl (desamino cysteinyl) residue, is an inhibitor of platelet aggregation and belongs to the class of rgd (arginine-glycine-aspartate)-mimetics.
마지막 업데이트: 2017-04-26
사용 빈도: 5
품질: